These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 32852635)

  • 41. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.
    Harimoto N; Yoshizumi T; Fujimoto Y; Motomura T; Mano Y; Toshima T; Itoh S; Harada N; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
    World J Surg; 2018 Aug; 42(8):2606-2616. PubMed ID: 29372372
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radiofrequency ablation compared to resection in early-stage hepatocellular carcinoma.
    Tohme S; Geller DA; Cardinal JS; Chen HW; Packiam V; Reddy S; Steel J; Marsh JW; Tsung A
    HPB (Oxford); 2013 Mar; 15(3):210-7. PubMed ID: 23374361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined hepatectomy and radiofrequency ablation for multifocal hepatocellular carcinomas: long-term follow-up results and prognostic factors.
    Choi D; Lim HK; Joh JW; Kim SJ; Kim MJ; Rhim H; Kim YS; Yoo BC; Paik SW; Park CK
    Ann Surg Oncol; 2007 Dec; 14(12):3510-8. PubMed ID: 17653800
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
    Yang W; Wu H; Zhang ZY; Lee JC; Wang S; Wang YJ; Wu W; Chen MH; Yan K
    Int J Hyperthermia; 2018 Feb; 34(1):68-76. PubMed ID: 28540818
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salvage liver transplantation for recurrent hepatocellular carcinoma within UCSF criteria after liver resection.
    Liu F; Wei Y; Wang W; Chen K; Yan L; Wen T; Zhao J; Xu M; Li B
    PLoS One; 2012; 7(11):e48932. PubMed ID: 23145027
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
    Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials.
    Wang Y; Luo Q; Li Y; Deng S; Wei S; Li X
    PLoS One; 2014; 9(1):e84484. PubMed ID: 24404166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel nomogram for prediction of intrahepatic recurrence-free survival in patients with HCC followed by radiofrequency ablation.
    Wang B; Wu H; Wang S; Zhang ZY; Wu W; Yan K; Yang W
    Br J Radiol; 2024 Mar; 97(1156):844-849. PubMed ID: 38346708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.
    Ng KKC; Chok KSH; Chan ACY; Cheung TT; Wong TCL; Fung JYY; Yuen J; Poon RTP; Fan ST; Lo CM
    Br J Surg; 2017 Dec; 104(13):1775-1784. PubMed ID: 29091283
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognosis of radiofrequency ablation versus hepatic resection for patients with colorectal liver metastases: A systematic review and meta-analysis based on 22 studies.
    Yang G; Wang G; Sun J; Xiong Y; Li W; Tang T; Li J
    Int J Surg; 2021 Mar; 87():105896. PubMed ID: 33588125
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of resection and ablation for single hypovascular hepatocellular carcinoma ≤2 cm analysed with propensity score weighting.
    Takayasu K; Arii S; Sakamoto M; Matsuyama Y; Kudo M; Kaneko S; Nakashima O; Kadoya M; Izumi N; Takayama T; Ku Y; Kumada T; Kubo S; Kokudo T; Hagiwara Y; Kokudo N;
    Liver Int; 2018 Mar; 38(3):484-493. PubMed ID: 29266722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation? A Retrospective Cohort Study.
    Zhang X; Li C; Wen T; Peng W; Yan L; Yang J
    Int J Surg; 2017 Oct; 46():178-185. PubMed ID: 28890407
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.
    Doyle A; Gorgen A; Muaddi H; Aravinthan AD; Issachar A; Mironov O; Zhang W; Kachura J; Beecroft R; Cleary SP; Ghanekar A; Greig PD; McGilvray ID; Selzner M; Cattral MS; Grant DR; Lilly LB; Selzner N; Renner EL; Sherman M; Sapisochin G
    J Hepatol; 2019 May; 70(5):866-873. PubMed ID: 30615906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Living donor liver transplantation for hepatocellular carcinoma in patients exceeding the UCSF criteria.
    Fouzas I; Sotiropoulos GC; Lang H; Nadalin S; Beckebaum S; Sgourakis G; Saner FH; Radtke A; Papanikolaou V; Baba HA; Paul A; Broelsch CE; Malagó M
    Transplant Proc; 2008 Nov; 40(9):3185-8. PubMed ID: 19010228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term Favorable Outcomes of Radiofrequency Ablation for Hepatocellular Carcinoma as an Initial Treatment: A Single-center Experience Over a 10-Year Period.
    Tsukamoto M; Yamashita YI; Imai K; Umezaki N; Yamao T; Kaida T; Mima K; Nakagawa S; Hashimoto D; Chikamoto A; Ishiko T; Baba H
    Anticancer Res; 2018 Feb; 38(2):1047-1052. PubMed ID: 29374739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation.
    Park MS; Lee KW; Suh SW; You T; Choi Y; Kim H; Hong G; Yi NJ; Kwon CH; Joh JW; Lee SK; Suh KS
    Transplantation; 2014 Jan; 97(1):71-7. PubMed ID: 24056623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma Within or Beyond the Milan Criteria: Comparable Long-Term Outcomes.
    Lee S; Song GW; Kim KW; Kwon JH; Lee SG
    Transplant Proc; 2021; 53(1):92-97. PubMed ID: 33288309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Radiofrequency ablation versus surgical resection in elderly patients with early-stage hepatocellular carcinoma in the era of organ shortage.
    Yu B; Ding Y; Liao X; Wang C; Wang B; Chen X
    Saudi J Gastroenterol; 2018; 24(6):317-325. PubMed ID: 30117492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.